Synopsis
The classic reference to psychotropic medications, with substantial revisions and updates: packed with new and expanded comparison charts, the latest drugs, new section on pharmacogenomics, and much more! ? New chapter on pharmacogenomics ? New Section with NbN (Neuroscience-based Nomenclature) classification of psychotropics ? Substantial revisions of chapters on antipsychotics, BLT, rTMS, natural health products ? Comparisan chart outlining relative tolerability profiles of antipsychotics ? Chart for laboratory and clinical monitoring of antipsychotics ? Substantially revised comparison charts of agents for treating acute extrapyramidal side effects ? Added new drugs and formulations ? More information on unapproved treatments
About the Author
Ric M. Procyshyn, BSc (Pharm), MSc, PharmD, PhD is affiliated with the British Columbia Mental Health & Addictions Research Institute and Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
Kalyna Z. Bezchlibnyk-Butler, BScPhm, FCSHP is in private practice.
J. Joel Jeffries, MB, FRCPC is affiliated with the Centre for Addiction andMental Health and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
"About this title" may belong to another edition of this title.